SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950142-01-000152
Filing Date
2001-03-22
Accepted
2001-03-22 00:00:00
Documents
3
Group Members
FRANK H. PEARLPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, LPPERSEUS-SOROS PARTNERS, LLCRAPPAHANNOCK INVESTMENT COMPANYSFM AH, INC.SFM PARTICIPATION, LPSOROS FUND MANAGEMENT LLCSOROS GEORGE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 0001.txt SC 13G 33411
2 EXHIBIT 1 0002.txt EX-99 4848
3 EXHIBIT 2 0003.txt EX-24 2367
  Complete submission text file 0000950142-01-000152.txt   43135
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 41 UNIVERSITY DRIVE NEWTON PA 18940
Business Address 41 UNIVERSITY DRIVE NEWTON PA 18940 2155797388
COLLAGENEX PHARMACEUTICALS INC (Subject) CIK: 0001012270 (see all company filings)

IRS No.: 521758016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47825 | Film No.: 1576047
SIC: 2834 Pharmaceutical Preparations